Advertisement

Topics

Onyx Pharmaceuticals to Report First Quarter 2012 Financial Results After Market on May 2, 2012

13:51 EDT 8 Oct 2017 | PR Newswire

SOUTH SAN FRANCISCO, April 18, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will report financial results for the first quarter ended March 31, 2012 after market closes on Wednesday, May 2, 2012.  The company will host a webcast and conference call with management to discuss financial results, as well as provide a general business overview, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). 

To access a live audio webcast of the conference call, log onto the company's website at:
http://www.onyx.com/investors/event-calendar

To access the live conference call, dial 847-585-4405 and use the passcode 32270630#.  A replay of the call will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 32270630# approximately one hour after the teleconference concludes through May 16, 2012. 

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.  The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.

SOURCE Onyx Pharmaceuticals, Inc.

NEXT ARTICLE

More From BioPortfolio on "Onyx Pharmaceuticals to Report First Quarter 2012 Financial Results After Market on May 2, 2012"

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...